entertainment -WSS

entertainment

author：comprehensive 2025-09-27 18:29:21 - browse：63695

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： New chief aims to remake Sanofi Genzyme

WSS

Supreme Court rules employers must be more accommodating of religious observance

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

New chart reveals military’s vast involvement in Operation Warp Speed

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

The simple reason for the increase in autism diagnosis

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

hotspot

entertainment

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

ADA: All diabetes patients should be screened for liver condition

Psychedelics group wrestles with new pharma identity

Reframing the conversation around gain

Hollywood unions extend contract negotiations for actors

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Apple is now the first public company to be valued at $3 trillion

Synthetic human embryos? Researchers say term is overblown

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Trump Organization, Michael Cohen agree to settle million

hotspot

It's time to take a new tack for treating Alzheimer's

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

'The View' co

entertainment

leisure time

Wikipedia

hotspot